About bone and mineral diagnostic testing
Bone and mineral disorders are caused by deficiency of minerals such as calcium, phosphorus, vitamin D, and abnormalities of bone structure or bone mass. Osteoporosis, Paget's disease, and osteogenesis imperfecta are some of the common bone diseases. Bone and mineral diagnostic tests are used for diagnosis and assessment of changes in response to bone disorder therapy. These tests are performed using technologies such as ELISA, CLIA, and RIA.
Technavio's analysts forecast the global bone and mineral diagnostic testing market to grow at a CAGR of 4.33% over the period 2014-2019.
Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the global bone and mineral diagnostic testing market for the period 2015-2019. To calculate the market size, we use revenue generated from the sales of the following product application categories:
Vitamin D testing
Bone metabolism testing (osteocalcin, parathyroid hormone (PTH), and bone alkaline phosphatase (BAP) assays)
Technavio's report, Global Bone and Mineral Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas APAC, and EMEA; it also covers the landscape of the global bone and mineral diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
Americas
APAC
EMEA
Key vendors
Abbott Diagnostic
bioMrieux
Diasorin
Quidel
Roche Diagnostic
Siemens Healthcare
Other prominent vendors
Alere
ALPCO
Beckman Coulter
Biomedica Immunoassays
Bio-Rad Laboratories
Calbiotech
DIAsource ImmunoAssays
DRG INSTRUMENTS
Eagle BioSciences
Enzo Life Sciences
Epitope Diagnostics
IASON
IBL International
Immundiagnostik
Immunodiagnostic Systems
ORGENTEC Diagnostika
Orion Diagnostica
Ortho-Clinical Diagnostics
TECOmedical
Market driver
Increasing incidences of bone disorders
For a full, detailed list, view our report
Market challenge
Pricing erosion in established countries
For a full, detailed list, view our report
Market trend
Development in automation of assay
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Reimbursement and coverage: An overview
Current scenario: Validating diagnostic tests
Reimbursement structure in the US
Reimbursement structure in EU
Prevailing issues of reimbursement policies
PART 07: Market segmentation by application
Vitamin D testing
Bone metabolism
PART 08: Market segmentation by technology
ELISA
CLIA
Other tests
PART 09: Market segmentation by product
Assays/consumables
Instruments
PART 10: Geographical segmentation
Bone and mineral diagnostic testing market in Americas
Bone and mineral diagnostic testing market in EMEA
Bone and mineral diagnostic testing market in APAC
PART 11: Market drivers
Increasing incidence of bone disorders
Early diagnosis and preventive medicine
Increase in geriatric population
PART 12: Impact of drivers
PART 13: Market challenges
Pricing erosion in established countries
Limited detection capability and complexity
Reimbursement and regulatory hurdles
PART 14: Impact of drivers and challenges
PART 15: Market trends
Development in automation of assays
Growing focus on emerging countries
Focus on POC diagnostic tests
Increase in awareness and role of government and non-profit institutions
PART 16: Vendor landscape
Competitive scenario
Key vendor analysis 2014
Other prominent vendors
PART 17: Key vendor analysis
Abbott Diagnostics
bioMrieux
DiaSorin
Roche Diagnostics
Siemens Healthcare
Quidel
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global bone and mineral diagnostic testing market 20142019 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Reimbursement perspectives of healthcare entities
Exhibit 05: Global bone and mineral diagnostic testing market segmentation by application
Exhibit 06: Segmentation of global bone and mineral diagnostic testing market by application 2014
Exhibit 07: Global vitamin D diagnostic testing market 20142019 ($ millions)
Exhibit 08: Global bone metabolism diagnostic testing market 20142019 ($ millions)
Exhibit 09: Global bone and mineral diagnostic testing market by application 20142019
Exhibit 10: Global bone and mineral diagnostic testing market segmentation by technology
Exhibit 11: Segmentation of global bone and mineral diagnostic testing market by product 2014
Exhibit 12: Segmentation of global bone and mineral diagnostic testing market by geography 2014
Exhibit 13: Segmentation of global bone and mineral diagnostic testing market by geography 2019
Exhibit 14: Segmentation of global bone and mineral diagnostic testing market by geography 20142019
Exhibit 15: Bone and mineral diagnostic testing market in Americas 20142019 ($ millions)
Exhibit 16: Bone and mineral diagnostic testing market in EMEA 20142019 ($ millions)
Exhibit 17: Bone and mineral diagnostic testing market in APAC 20142019 ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Estimated healthcare spending in BRIC countries in 2015 ($ billions)
Exhibit 21: Key takeaways: Abbott Diagnostics
Exhibit 22: Key takeaways: bioMrieux
Exhibit 23: DiaSorin: Key takeaways
Exhibit 24: Roche Diagnostics: Key takeaways
Exhibit 25: Siemens Healthcare: Key takeaways
Exhibit 26: Quidel: Key takeaways
Exhibit 27: Abbott Diagnostics: Key business offerings
Exhibit 28: bioMrieux: Applications by technology
Exhibit 29: DiaSorin: Business segmentation by revenue 2014
Exhibit 30: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 31: DiaSorin: Geographical segmentation by revenue 2014
Exhibit 32: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 33: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 34: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 35: Siemens Healthcare: Business segmentation
Exhibit 36: Siemens Healthcare: Geographical segmentation by revenue 2014
Exhibit 37: Quidel: Product segmentation by revenue 2014
Exhibit 38: Quidel: Product segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 39: Quidel: Geographical segmentation by revenue 2014
